Home › Core › ISCC-IDs › 28CrYC2hjBxuZ

View ISCC-ID

Core Data

28CrYC2hjBxuZ
ISCC-ID - digital asset identifier
CC5z1EqvqSWmx-CThwBUikJznWe-CDfMEMFE7DS5Y-CRaKvoWqDBApo
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

effect of gemigliptin switching from pioglitazone with metformin in type 2 diabetes

Ledger Reference

coblo
Source Ledger/Blockchain
43075
N-th ISCC Decleration on source ledger
36718be31dad2c6a4b656a7dacf2b93b5a627857919b989033073cadc40ca1ef
Hash of block that includes the ISCC-DECLARATION
9eb4487b1cdac7a7aebd0f5bf5c5d97d23cb9a86b87c011e9f9f097eea0692ba
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Effect of gemigliptin switching from pioglitazone with metformin in type 2 diabetes", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Yonghyun Kim", "@type": "Person"}, {"name": "Donghyun Shin", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.endocrine-abstracts.org/ea/0037/eposters/ea0037ep499_eposter.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "BioScientifica", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1530/endoabs.37.ep499", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CC5z1EqvqSWmx-CThwBUikJznWe-CDfMEMFE7DS5Y-CRaKvoWqDBApo", "propertyID": "ISCC"}], "datePublished": "2015-05-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close